Search research articles
Contact Us
Filters
Showing results (301-310 of 352) with videos related to
Page
of 36
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
Nanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
Euroasian Journal of Hepato-Gastroenterology
|
March 5, 2019
International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G
Richard Hunt, Leonid B Lazebnik, Yury C Marakhouski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 10, 2024
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Lindsey Greenlund, Claire Herzog, Zachary Wendland, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
BMJ Open
|
February 6, 2024
Protocol of a scoping review of outcome domains in dermatology
Umer Nadir, Areeba Ahmed, Michael D Yi, et al.
Anti-Cancer Drugs
|
July 16, 2019
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer
Yang Luo, Wei Li, Zefei Jiang, et al.
The Journal of Rheumatology
|
November 1, 2022
Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Dhruvkumar Laheru, Anna Antony, Sueli Carneiro, et al.
Clinical Pharmacokinetics
|
April 12, 2024
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
Mei Tang, Amit Garg, Peter L Bonate, et al.
Archives of Dermatological Research
|
October 28, 2022
The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum
Jonathan Rick, Lisa J Gould, Angelo Valerio Marzano, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2019
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
Whitney P Kirschbrown, Matts Kågedal, Bei Wang, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 352) with videos related to
Sort By:
Page
of 36
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping review
Nanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
Euroasian Journal of Hepato-Gastroenterology
|
March 5, 2019
International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G
Richard Hunt, Leonid B Lazebnik, Yury C Marakhouski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 10, 2024
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients
Lindsey Greenlund, Claire Herzog, Zachary Wendland, et al.
American Journal of Clinical Dermatology
|
March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment
Antonio Martorell, John R Ingram, Christopher J Sayed, et al.
BMJ Open
|
February 6, 2024
Protocol of a scoping review of outcome domains in dermatology
Umer Nadir, Areeba Ahmed, Michael D Yi, et al.
Anti-Cancer Drugs
|
July 16, 2019
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer
Yang Luo, Wei Li, Zefei Jiang, et al.
The Journal of Rheumatology
|
November 1, 2022
Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Dhruvkumar Laheru, Anna Antony, Sueli Carneiro, et al.
Clinical Pharmacokinetics
|
April 12, 2024
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors
Mei Tang, Amit Garg, Peter L Bonate, et al.
Archives of Dermatological Research
|
October 28, 2022
The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum
Jonathan Rick, Lisa J Gould, Angelo Valerio Marzano, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2019
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
Whitney P Kirschbrown, Matts Kågedal, Bei Wang, et al.
Page
of 36